Table 3.
Measurement conditions
| Number (percentage) or median [25–75% interquartile range] | |
|---|---|
| Intubation | |
| Yes | 391 (53) |
| No | 341 (47) |
| Ventilation mode (If intubated) | |
| Controlled | 181 (46) |
| Spontaneous | 210 (54) |
| Ventilation mode (If not intubated) | |
| Non-invasive ventilation | 8 (2) |
| High-flow nasal cannula oxygen | 34 (10) |
| Nasal cannula | 299 (88) |
| Mean arterial pressure (mmHg) | 93 (22) |
| Heart rate (BPM) | 79 (19) |
| Pulse pressure (mmHg) | 78 (18) |
| Norepinephrine infusion | |
| Yes | 218 (32) |
| Dose (μg/kg/min) | 0.39 (0.33) |
| Milrinone | |
| Yes | 67 (10) |
| Dose (μg/kg/min) | 1.9 [0.8–2.0] |
| Urapidil | |
| Yes | 84 (12) |
| Dose (mg/h) | 50 [20–60] |
| Nicardipine | |
| Yes | 28 (4) |
| Dose (mg/h) | 8 [6–9] |
| Sedation | |
| Yes | 101 (15) |
| No | 585 (85) |
| RASS score (if sedation) | |
| − 5 | 83 (86) |
| − 4 | 13 (13) |
| − 3 to 2 | 1 (1) |
| Glasgow score (If no sedation) | |
| 3–7 | 32 (8) |
| 8–11 | 103 (26) |
| 11–15 | 259 (66) |
| Propofol | |
| Yes | 59 (9) |
| Dose (mg/h) | 200 [120–240] |
| Sufentanil | |
| Yes | 117 (17) |
| Dose (μg/h) | 40 [20–60] |
| Midazolam | |
| Yes | 59 (9) |
| Dose (mg/h) | 10 [5–20] |